It is a common perception that approximately 50% of heart failure (HF) patients present with a normal or near-normal left ventricular (LV) ejection fraction ("HF with preserved systolic function"), ...

Please provide your email address to receive an email when new articles are posted on . Empagliflozin, an SGLT2 inhibitor, improved left ventricular function and quality of life in patients with HF ...

The study covered in this summary was published in researchsquare.com as a preprint and has not yet been peer reviewed. Pericoronary adipose tissue (PCAT) fat attenuation index (FAI) associated with ...

For patients who have heart failure with reduced ejection fraction (HFrEF) and coronary artery disease, improvements in LV function after revascularization are linked to better long-term outcomes, an ...

Focused cardiac ultrasonography is a point-of-care, qualitative or semiquantitative means of assessing cardiac size, structure, and function that is performed and interpreted by the clinician at the ...

Researchers at the Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, and the University of Utah School of Medicine, have demonstrated that a gene therapy can ...

Please provide your email address to receive an email when new articles are posted on . 4D model-guided cardiac resynchronization lead placement improved left ventricular function vs. standard care.

Cardiac MRI scan FGF23 levels may be associated with lower LV systolic function, higher LV mass, and lower LA function. Fibroblast growth factor 23 (FGF23) levels may be associated with lower left ...